From the New Diagnostic Criteria to COVID-19 Pandemic Passing Through the Placebo Effect. What Have We Learned in the Management of Pediatric Migrane Over the Past 5 Years?

In 2018, the Food and Drug Administration (FDA) approval of anti-calcitonin gene-related peptide (CGRP) therapies for the treatment of migraine represented a milestone for the management of the disease in adults. On the contrary, the novelties in the field of pediatric migraine are inserted in a dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Papetti, Laura, Tarantino, Samuela, Ursitti, Fabiana, Moavero, Romina, Proietti, Martina Checchi, Sforza, Giorgia, Monte, Gabriele, Ferilli, Michela Ada Noris, Balestri, Martina, Vigevano, Federico, Valeriani, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326104/
https://www.ncbi.nlm.nih.gov/pubmed/35911893
http://dx.doi.org/10.3389/fneur.2022.935803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326104/
https://www.ncbi.nlm.nih.gov/pubmed/35911893
http://dx.doi.org/10.3389/fneur.2022.935803

Ejemplares similares